Woman Banned for Decade from Importing Drugs After Conviction
Published Date: 4/23/2026
Notice
Summary
Kimberly Schaff Kiehl is banned for 10 years from importing any drugs into the U.S. because she was convicted of serious crimes related to drug importation. She didn’t respond to the FDA’s notice, so the ban started on April 23, 2026. She can apply to end the ban anytime, but must follow special rules to keep some info private.
Analyzed Economic Effects
3 provisions identified: 0 benefits, 2 costs, 1 mixed.
10-Year Drug Import Ban
Ms. Kimberly Schaff Kiehl is debarred for 10 years from importing or offering for import any drug into the United States, effective April 23, 2026. The debarment follows her July 3, 2025 federal felony convictions for mail fraud and causing counterfeit drugs to be made, sold, or held for sale.
Helping Debarred Importer Is Prohibited
Pursuant to section 301(cc) of the FD&C Act, importing or offering for import any drug into the United States by, with the assistance of, or at the direction of Ms. Kiehl is a prohibited act effective April 23, 2026. Third parties cannot legally import drugs for or on behalf of Ms. Kiehl during her 10-year debarment.
Debarment-End Application Privacy Rules
Ms. Kiehl may apply at any time to terminate the debarment under section 306(d)(1). If she files the application electronically to https://www.regulations.gov it and attachments will be posted publicly unchanged; to keep confidential information private she must submit a written/paper application with two copies (one marked confidential and one redacted) as described in the notice.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20727, Medical Devices; Immunology and Microbiology Devices; Classification of the System for Detection of Nucleic Acid From Non-Viral Microorganism(s) Causing Sexually Transmitted Infections Using Home-Collected Specimens
The FDA is officially classifying home test kits that detect non-viral germs causing sexually transmitted infections as Class II devices, meaning they have special safety rules but fewer hurdles than the strictest category. This change, effective October 9, 2026, helps make these tests safer and easier to get, benefiting patients and innovators alike. If you make or use these home test kits, this update means better access and clear safety standards without extra costs or delays.
Previous / Next Documents
Previous: 2026-07859, Paperwork Reduction Act; Proposed Collection; Comment Request
The Office of National Drug Control Policy wants your thoughts on updating how they collect info for two programs fighting youth drug abuse. These changes affect communities using Drug-Free Communities and CARA grants, aiming to better track progress against opioid and meth use among teens. You’ve got 60 days to share your ideas, helping shape smarter, more effective drug prevention efforts without adding extra paperwork headaches.
Next: 2026-07866, Wooden Cabinet and Vanities and Components Thereof From the People's Republic of China: Final Results and Recission, in Part, of Antidumping Duty Administrative Review; 2023-2024
The U.S. Department of Commerce found that two Chinese companies, Ancientree and KM Cabinetry, sold wooden cabinets and vanities at unfairly low prices from April 2023 to March 2024. This means they’ll face extra duties to level the playing field for U.S. businesses. These changes take effect April 23, 2026, and could impact import costs and prices.